Hub

China healthcare system hub

China’s healthcare system needs to be understood as an internal institutional system, not merely as a market opportunity.

Glossary Source methodology Sitemap

1Start with structureRead the overview before specialized pages.

2Use comparisons carefullySimilar words often describe different institutions.

3Check maintenance markersRegulatory and payment pages change more quickly.

4Follow internal linksThe site is designed as a reference graph.

Core pages

Recommended starting points

These pages define the cluster and point to more specialized pages as the site build expands.

Core system

Healthcare in China

A system-level guide to the structure, financing, delivery institutions, and reform questions that shape healthcare in China.

Delivery

Public hospitals

The hospital-centered delivery system and its reform pressures.

Financing

Health insurance

Coverage, reimbursement, NHSA, and payment reform.

Cluster index

Current foundation links

Start HereReader orientation GlossaryTerms Source MethodologySources SitemapFull index 2012 ArchiveHistorical material Editorial StandardsMaintenance rules

System architecture

China healthcare system core pages

These pages form the first substantive layer of the China healthcare system reference library.

Healthcare in ChinaChina healthcare system Healthcare Reform in ChinaReform brief Health in ChinaData reference Medicine in ChinaMedicine and history Healthcare Governance in ChinaIssue map Public Hospitals in ChinaHospitals in China Private Hospitals in ChinaHospitals in China Primary Care in ChinaPrimary care Rural Healthcare in ChinaRural health Urban Healthcare in ChinaUrban health County Hospitals in ChinaInstitutional profile Community Health Centers in ChinaInstitutional profile Village Clinics in ChinaInstitutional profile Referral Systems in ChinaVisual explainer Medical Alliances in ChinaPolicy instrument Family Doctor Programs in ChinaReform brief Health Informatization in ChinaHealth information Healthcare Financing in ChinaHealthcare financing Out-of-Pocket Spending in ChinaData reference Healthcare Inequality in ChinaIssue map

Hospital architecture

Chinese hospitals architecture pages

These pages explain hospital hierarchy, classification, governance, specialty institutions, and hospital-related system stress.

Hospital profile layer

National and major hospital profiles

These pages map prominent Chinese hospitals by institutional role, city, specialty relevance, and strategic interpretation.

Regional profile layer

City healthcare and additional hospital profiles

These pages extend the hospital layer beyond Beijing and Shanghai and add city-level healthcare geography.

Regional profile layer

Province and regional healthcare profiles

These pages describe how China’s healthcare system varies by province, macro-region, geography, economy, and access pattern.

Insurance and financing layer

Health insurance and financing architecture

These pages explain insurance coverage, basic medical insurance programs, reimbursement, supplemental coverage, patient cost sharing, and NHSA-related financing architecture.

Payment and procurement reform layer

Payment, procurement, pricing, and incentive pages

These pages explain how China uses procurement, reimbursement, service pricing, payment reform, and compliance pressure to change healthcare economics.

Volume-Based Procurement in Chinaprocurement and price-control policy instrument Drug Volume-Based Procurement in Chinadrug procurement and price-volume tradeoff Medical Device Volume-Based Procurement in Chinadevice and consumables procurement reform High-Value Medical Consumables Procurement in Chinamedtech-specific procurement pathway National Drug Price Negotiations in ChinaNRDL-linked drug pricing mechanism NRDL Negotiation Strategy for Drug Companiescompany playbook for NRDL access Zero Markup Drug Policy in Chinapublic hospital revenue reform Public Hospital Compensation Reform in Chinapublic hospital incentive and revenue redesign DRG Payment in Chinadiagnosis-related group payment reform DIP Payment Reform in ChinaBig Data Diagnosis-Intervention Packet reform Global Budgets in Chinese Healthcarepayer budget constraint Capitation Pilots in Chinapopulation-based payment experiment Fee-for-Service in Chinapayment method and reform target Essential Medicines in Chinaprimary-care and medicine policy term Centralized Procurement in Chinese Healthcarecentralized purchasing architecture beyond VBP Two-Invoice System in Chinapharmaceutical distribution reform Medical Price Controls in Chinapricing administration across products and services Medical Service Pricing Reform in Chinaservice price reform in public hospitals Provider Incentives in Chinese Hospitalsincentive map around hospitals and physicians Healthcare Anti-Corruption Campaigns in Chinagovernance and procurement risk issue

History and TCM layer

History, public health, and Traditional Chinese Medicine pages

These pages explain Chinese medical history, reform eras, public-health shocks, TCM institutions, regulation, exports, and scientific debate.

History of Medicine in Chinahistorical timeline Imperial Medicine in Chinaclassical and court medicine Republican-Era Medicine in Chinamodernization before the People’s Republic Mao-Era Healthcarecollectivized healthcare and mass public health Barefoot Doctorsgrassroots rural health worker Patriotic Health Campaignspublic-health mobilization Healthcare Under the Planned Economy in Chinaplanned economy financing and delivery Market Reforms and Chinese Healthcarepost-1978 marketization and its effects The 2009 Healthcare Reforms in Chinamodern reform launch point Five-Year Plans and Healthcare in Chinaplanning documents and policy priorities SARS and Chinese Public Health Reformpublic-health shock case study COVID-19 and Chinese Healthcaresystem stress and public-health governance Traditional Chinese Medicineinstitution, practice, market, and identity Traditional Chinese Medicine and National Identitysymbolic and policy issue map Traditional Chinese Medicine Hospitals in Modern Chinaformal institutional profile Acupuncture in Chinapractice and international translation Chinese Herbal Medicinepractice, industry, and regulatory category Regulation of Traditional Chinese Medicineregulation and governance pathway TCM Exportsexport ambitions and barriers Scientific Debate Around Traditional Chinese Medicinemyth-versus-fact evidence page

Population health layer

Population health, disease burden, and public-health pages

These pages connect Chinese epidemiology to prevention, delivery-system capacity, financing, and regional variation.

Life Expectancy in Chinamortality and system progress indicator Infant Mortality in Chinachild survival and public-health capacity indicator Maternal Mortality in Chinamaternal health and system-capacity indicator Chronic Disease in Chinamain system-pressure category Cancer in Chinaoncology burden and capacity issue Cardiovascular Disease in Chinacardiometabolic and specialty-care pressure Stroke in Chinaacute and chronic neurological burden Diabetes in Chinametabolic disease and primary-care challenge Obesity in Chinanutrition transition and future risk factor Smoking in Chinatobacco and political economy issue Mental Health in Chinacapacity, stigma, and service-system issue Suicide in Chinamortality and social-health indicator Infectious Diseases in Chinasurveillance and public-health governance issue Tuberculosis in ChinaTB program and public-health control issue Hepatitis in Chinaviral hepatitis burden and prevention issue HIV/AIDS in Chinapublic-health and treatment-system issue Vaccination in Chinaimmunization system and confidence issue Food Safety and Health in Chinapublic-health governance and trust issue Occupational Health in Chinaworkplace risk and industrial health issue Air Pollution and Health in Chinaenvironmental exposure and disease burden issue

Aging and social-protection layer

Aging, migration, family structure, and social-protection pages

These pages connect demographic change, household risk, local access, insurance, social care, and medical impoverishment.

Aging Population and Healthcare in Chinasystem-wide aging pressure Long-Term Care in Chinacare infrastructure and financing issue Eldercare in Chinafamily, community, residential, and medical care mix Pension and Healthcare Interaction in Chinaretirement security and medical burden issue map Rural Elderly Healthcare in Chinarural aging and access constraint Migrant Workers and Healthcare in Chinamobility, insurance portability, and urban access issue Hukou and Healthcare Accessregistration status and benefit access mechanism Left-Behind Children and Health in Chinamigration and child-health consequence Maternal Health in Chinamaternal-child health system page Child Health in Chinachild health and pediatric access page Reproductive Health in Chinaservice access and demographic policy context One-Child Policy Health Effectsdemographic policy case study Fertility Policy and Healthcare in Chinafertility transition and healthcare demand issue Disability Care in Chinarehabilitation, benefits, and access issue Rehabilitation Medicine in Chinapost-acute and functional recovery capacity Palliative Care in Chinaserious illness and end-of-life care development Rare Diseases in Chinadiagnosis, access, and policy challenge Orphan Drugs in Chinarare disease regulatory and reimbursement pathway Catastrophic Illness in Chinasevere illness and household financial risk Medical Poverty in Chinamedical impoverishment and residual risk

U.S.-China comparison layer

Researched U.S.-China comparison pages

These pages compare the institutional mechanisms that drive access, payment, provider behavior, technology adoption, and regulation in the two systems.

U.S. vs. China Healthcare Systemsystem architecture comparison U.S. vs. China Health Insuranceinsurance architecture and financial protection comparison U.S. vs. China Hospitalshospital role, ownership, hierarchy, and patient behavior U.S. vs. China Primary Caregatekeeping, community care, and first-contact access U.S. vs. China Rural Healthcarerural access with different institutional causes U.S. vs. China Urban Healthcareurban concentration and navigation problem U.S. vs. China Public Healthpublic-health administration and state capacity U.S. vs. China Aging and Healthcareaging pressure, family structure, and financing U.S. vs. China Long-Term Carelong-term care financing and delivery U.S. vs. China Physician Workforcetraining, compensation, status, and practice environment U.S. vs. China Nursing Workforcenursing supply, role, and staffing context U.S. vs. China Medical Educationmedical training, licensing, and career pathway U.S. vs. China Hospital PaymentDRGs, FFS, budgets, payer contracts, and incentives U.S. vs. China Drug PricingPBMs, Medicare, NRDL, VBP, and negotiation U.S. vs. China Medical Device Pricinghospital purchasing, GPOs, VBP, and value analysis U.S. vs. China Reimbursementpayment pathways for products and services U.S. vs. China Health Technologyadoption environment for digital health and medtech U.S. vs. China Telehealthtelehealth regulation, payment, and adoption patterns U.S. vs. China Healthcare Data PrivacyHIPAA versus PIPL and data-security context U.S. vs. China AI Governance in Healthcaremedical AI regulation, data governance, and adoption

Regulatory strategy layer

Regulation, approval, trials, and postmarket governance pages

These pages analyze FDA and NMPA pathways, drug and device approval, clinical trials, real-world evidence, postmarket surveillance, software, cybersecurity, and regulatory localization.

FDA vs. NMPAregulator mandate and institutional operating model Drug Approval in the United States and Chinadrug evidence, review, and market-access sequencing Medical Device Approval in the United States and Chinaclassification, risk, evidence, and route-to-market Diagnostics Approval in the United States and ChinaIVD, laboratory, and clinical-use pathway Digital Therapeutics Regulation in the U.S. and Chinasoftware claims, clinical evidence, and payment uncertainty AI Medical Device Regulation in the U.S. and ChinaAI-enabled SaMD, lifecycle change, validation, and safety Clinical Trials in the U.S. and Chinatrial authorization, sites, ethics, and evidence transferability Human Subjects Research in Chinaethics, consent, institution, and participant protection Good Clinical Practice in Chinaclinical trial quality system Ethics Committees in Chinainstitutional research gatekeeper Postmarket Surveillance in Chinapost-approval safety and lifecycle control Pharmacovigilance in Chinadrug safety monitoring and risk management Medical Device Adverse Event Reporting in Chinadevice safety signal and corrective action Real-World Evidence in Chinaevidence beyond traditional trials Accelerated Approval Pathways in Chinapriority, breakthrough, conditional, and urgent-need review Breakthrough Medical Device Pathways in the U.S. and Chinaexpedited medtech review and market implications Companion Diagnostics in the U.S. and Chinadrug-diagnostic co-development and access Software as a Medical Device in Chinasoftware classification, registration, and lifecycle control Cybersecurity for Medical Devices in Chinadevice safety, data security, and network risk Regulatory Localization in Chinamarket-entry playbook for adapting global regulatory strategy

Governance and stakeholder layer

China healthcare agencies, laws, professional bodies, and stakeholder map

These pages explain agency roles, implementation authority, data laws, anti-corruption governance, professional regulation, medical education, HTA, and the larger Chinese healthcare stakeholder map.

National Health Commissioncentral health administration and delivery-system policy National Healthcare Security Administration Governance Roleinsurance, payment, procurement, and reimbursement governance National Medical Products Administrationdrug, device, diagnostic, and product regulator Chinese Center for Disease Control and Preventionpublic-health surveillance and disease-control institution Provincial Health Commissions in Chinalocal implementation and regional variation Hospital Associations in Chinaprofessional and institutional association influence Medical Specialty Societies in Chinaclinical norms, KOL networks, and specialty adoption China Academy of Chinese Medical SciencesTCM research and institutional knowledge production Chinese Medical Associationprofessional society and clinical influence National Medical Center Program in Chinacapacity-building and excellence-center policy instrument Healthy China 2030national health strategy and policy direction Basic Medical and Health Promotion Lawlegal framework for basic healthcare and health promotion Data Security Law and Healthcare in Chinadata-security obligations in health context Personal Information Protection Law and HealthcarePIPL implications for health data Cybersecurity Law and Healthcare in Chinanetwork security, critical systems, and healthcare operations Healthcare Anti-Corruption Governance in Chinaagencies, procurement, hospitals, and enforcement logic Physician Licensing in Chinalicensing pathway and professional regulation Medical Education Governance in Chinaeducation ministries, NHC, universities, and hospital training Health Technology Assessment in ChinaHTA as evidence bridge to reimbursement and policy Chinese Healthcare Stakeholder Maptop-level map of ministries, hospitals, insurers, regulators, and companies

Provider market and service-line layer

China provider markets, private care, service lines, and supplemental channels

These pages analyze public hospital reform, private and international care, hospital groups, checkups, rehabilitation, mental health, major service lines, commercial insurance, and employer health benefits.

Public Hospital Reform in Chinagovernance, pricing, compensation, and payment reform Private Hospital Strategy in Chinawhen private hospitals matter and when they do not Premium Private Healthcare in Chinahigh-end care market and demand limits International Hospitals in Chinaforeign-facing and premium private hospital segment United Family Healthcarehistorically important private and international hospital group Hospital Groups in Chinahospital groups, management companies, and health systems Medical Tourism in Chinainbound, outbound, and domestic specialty travel Health Checkup Centers in Chinapreventive screening, employer benefits, and consumer health market Rehabilitation Market in Chinaaging, stroke, post-acute care, and capacity gap Mental Health Market in Chinademand, stigma, workforce, hospitals, and digital platforms Oncology Care Strategy in Chinaservice-line strategy for cancer care, drugs, diagnostics, and hospitals Cardiovascular Care Strategy in Chinacardiovascular disease burden, tertiary hospitals, devices, and pathways Diabetes Care Strategy in Chinachronic care, primary care, devices, drugs, and digital management Ophthalmology Market in Chinaeye-care services, private chains, devices, and elective demand Dental Care Market in Chinaprivate-pay dentistry, implants, orthodontics, and clinic chains Fertility and Reproductive Services in Chinafertility policy, delayed childbearing, ART capacity, and regulation Elderly Care Market in Chinaeldercare services, long-term care insurance, and private participation Insurance Innovation in Chinacommercial insurance, city supplemental plans, and digital insurance Commercial Payer Strategy in Chinahow healthcare companies should think about commercial payers Employer Health Benefits in Chinaemployer health benefits as emerging supplemental channel